Jiayin Li

Jiayin Li is a Principal Scientist at IGNIS Therapeutics (Shanghai) Co., Ltd since May 2023, with prior experience as a Scientist II and Scientist I at Neurona Therapeutics from March 2019 to February 2023. At Neurona, Jiayin led teams in pre-clinical efficacy studies, facilitated cross-department collaboration, and contributed to the company's first pre-IND submission for a treatment targeting focal temporal lobe epilepsy. Earlier experience includes a tenure as a Research Associate at the University of Chinese Academy of Sciences, focusing on cellular and molecular mechanisms related to neuronal interactions, complemented by a Doctor of Philosophy in Neuroscience. Educational background includes a Master’s in Neuroscience and a Bachelor's in Biochemistry and Molecular Biology.